Our collaboration with the European Union Drugs Agency
When our collaboration with the European Union Drugs Agency (EUDA) wrapped up in March this year, it marked the end ...
Tag: OND
EU-CELAC drug observatories strengthen cooperation in the face of emerging challenges
Mexico City hosted, on 11 and 12 September 2025, the Meeting of National Drug Observatories (OND), an event promoted by ...
National Drug Observatories Facing New Global Challenges
The European Union's COPOLAD III programme, led by FIAP in consortium with IILA, and in partnership with EUDA and GIZ, ...
Cuba Launches National Drug Observatory with EU Support to Strengthen Evidence-Based Policy
Cuba has officially launched its new National Drug Observatory, a milestone initiative promoted by the Cuban Ministry of Justice and ...
Joint work with the Observatories of Latin America and the Caribbean
To show the progress achieved, as well as the challenges faced by the National Drug Observatories of Latin America and ...
Mexico launches a national research agenda on mental health and addictions
On Thursday 25 July 2024, the National Agenda of Research Priorities in Mental Health and Addictions was launched, developed with ...
Capacity-building online workshop on Early Warning Systems
On 20 March, the EMCDDA will organise an online capacity-building workshop on Early Warning Systems (EWS), in the framework of ...
Argentina advances in the inclusion of the gender approach in addiction treatment studies
Women are a minority among drug users, but, according to data from the United Nations Office on Drugs and Crime ...
Technical dialogue on drug evaluation policies in Uruguay
From October 23-27, 2023, the European Monitoring Centre for Drugs (EMCDDA), in the framework of COPOLAD, organized, together with the ...
4 new guides for National Drug Observatories
What institutional, human and financial resources do the National Drug Observatories have at their disposal to consolidate their national research ...
COPOLAD is a consortium formed by:
Collaborating partners:
